Mindfulness for Pain and Suicide
A Pilot Study on Mindfulness for Pain and Mental Health Outcomes
1 other identifier
interventional
76
1 country
1
Brief Summary
The proposed study will assess the feasibility and acceptability of a mindfulness-based intervention to reduce functional impairment from chronic pain and risk of suicide.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable chronic-pain
Started Mar 2023
Typical duration for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 28, 2022
CompletedFirst Posted
Study publicly available on registry
March 18, 2022
CompletedStudy Start
First participant enrolled
March 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 21, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 21, 2025
CompletedMarch 17, 2026
March 1, 2026
2 years
January 28, 2022
March 16, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Treatment acceptability
The Abbreviated Acceptability Rating Profile assesses the extent to which participants agree with 8 statements about the intervention. Scores range from 1 to 6 with higher scores indicating higher acceptability.
1-month post-treatment
Suicide risk
Suicide risk will be assessed using the Columbia Suicide Severity Rating Scale, which assesses presence and severity of suicidal ideation and behaviors in one's lifetime, over a specified period, and since the last visit. Presence of suicidal thoughts and behaviors are scored as either present (0) or absent (1) and severity is indicated as the most severe suicidal thought or behavior endorsed (from 0-none to 5-suicide attempt). Higher scores indicate more severe suicidal ideation and behaviors.
baseline to 6 months post-treatment follow-up
Depression
The Patient Health Questionnaire-9, a 9-item measure assessing frequency of depression symptoms in the last week. Rating scale is from 0 to 3 with higher scores indicating more frequent depression symptoms.
baseline to 6 months post-treatment follow-up
Interpersonal Needs
The Interpersonal Needs Questionnaire is a 12-item questionnaire measuring level of belonging and feeling like a burden to others. Items are rating on a scale ranging from 1 to 7 with higher scores indicate greater interpersonal conflict.
baseline to 6 months post-treatment follow-up
Pain Interference and intensity
Pain interference and intensity will be measured using the Brief Pain Inventory. Four items assessing current, average, worst, and least pain experienced. Pain interference is assessed over 7 items across various life domains. Items are rated from 0 to 10 with higher scores indicating more severe pain intensity and greater interference in activities due to pain.
baseline to 6 months post-treatment follow-up
Secondary Outcomes (6)
Health-related Quality of Life
baseline to 6 months post-treatment follow-up
Mindfulness
baseline to 6 months post-treatment follow-up
Pain acceptance
baseline to 6 months post-treatment follow-up
Pain catastrophizing
baseline to 6 months post-treatment follow-up
Pain-related self-efficacy
baseline to 6 months post-treatment follow-up
- +1 more secondary outcomes
Study Arms (2)
Mindfulness-Based Cognitive Therapy (MBCT)
EXPERIMENTALMBCT delivered over the course of 10, \~60 minute sessions
Health Education
ACTIVE COMPARATORHealth education sessions delivered over the course of 10, \~60 minute sessions
Interventions
10 sessions focused on increasing mindfulness awareness to address thoughts, emotions, and behaviors that maintain functional impairment and risk of suicide.
Health education provides information on the importance and benefits of and guidelines for living a healthy lifestyle.
Eligibility Criteria
You may qualify if:
- English-speaking veterans
- Ages 18 years and older
- Understand informed consent
- Report pain that occurs on at least half the days for six months or more
- Score at least a 4 on each item of the three items on a brief pain intensity and interference measure
- To meet the minimum threshold for suicide risk, veterans must meet at least one of the following: (1) endorse at least a 1 ("several days") on item 9 ("thoughts of you would be better off dead, or thoughts of hurting yourself in some way" in the past 2 weeks) of the Patient Health Questionnaire-9 (PHQ-9), (2) endorse at least "death ideation" in the last 3 months as measured by the Columbia Suicide Severity Rating Scale, or (3) report a suicide attempt in the last 6 months.
You may not qualify if:
- An active severe substance use disorder (SUD)
- Documented schizophrenia, active psychosis, or mania
- Upcoming surgeries
- Uncontrolled medical conditions
- Intent to carry out a plan for suicide.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Veterans Affairs Center of Excellence for Suicide Prevention
Canandaigua, New York, 14424, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2022
First Posted
March 18, 2022
Study Start
March 6, 2023
Primary Completion
March 21, 2025
Study Completion
March 21, 2025
Last Updated
March 17, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
Participant data is available upon request as part of scientific collaboration.